Published 2 years ago

U.S. FDA authorizes Pfizer's COVID booster shot for young children

Summary by Ground News

Pfizer requested this EUA at the end of April. Company data showed that a third vaccine dose raised Omicron-fighting antibodies by 36 times. 4,500 children ages 5 through 11 participated in the Pfizer/BioNTech Covid-19 vaccine trial.

0 Articles

All

Left

Center

Right

News18 India

US Authorises Covid Booster Shots for Children Aged 5 to 11 Years

The US Food and Drug Administration authorised children in the 5-11 group to receive the booster in order to provide continued protection against Covid-19, FDA Commissioner Robert Califf said in a statement

2 years ago·India

Read Full Article

The Hindu

U.S. FDA authorizes Pfizer's COVID booster shot for young children

The authorisation makes everyone in the United States aged five and above eligible for booster doses of the vaccine

2 years ago·India

Read Full Article

Reuters

U.S. FDA authorizes Pfizer's COVID booster shot for young children

The U.S. Food and Drug Administration has authorized the use of a booster shot of Pfizer and BioNTech's COVID-19 vaccine for children aged 5 to 11, the regulator said on Tuesday. The authorization makes everyone in the United States over the age of five eligible for booster doses of the vaccine, although the U.S. Centers for Diseas Control and Prevention still needs to sign off on the

2 years ago·United Kingdom

Read Full Article

CBC News

U.S. FDA clears Pfizer's COVID booster shot for young children | CBC News

The U.S. Food and Drug Administration has authorized the use of a booster shot of Pfizer and BioNTech's COVID-19 vaccine for children aged 5 to 11.

2 years ago·Canada

Read Full Article

Associated Press News

FDA clears COVID booster shot for healthy kids ages 5 to 11

U.S. regulators on Tuesday authorized a COVID-19 booster shot for healthy 5- to 11-year-olds, hoping an extra vaccine dose will enhance their protection as infections once again creep upward. Everyone 12 and older already was supposed to get one booster dose for the best protection against the newest coronavirus variants -- and some people, including those 50 and older, can choose a second booster.

2 years ago·United States

Read Full Article

USA Today

FDA authorizes Pfizer COVID vaccine booster for children 5 to 11

FDA authorized the Pfizer-BioNTech COVID booster for children ages 5 to 11 five months after they have finished the first two-shot vaccination series.

2 years ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.